Maccura Biotechnology Co., Ltd.
Maccura Biotechnology Co., Ltd.
Maccura Biotechnology Co., Ltd. (referred to as “Maccura”) i…
Main Products
Fully Automated Hematology Analyzer F880; Fully Automated Hematology Analyzer F600; Fully Automated Chemiluminescence Analyzer i800; Fully Automated Chemiluminescence Analyzer i6000; Fully Automated Coagulation Analyzer H3800; Laboratory-Wide Intelligent Pipeline Tla Labas mix
Certifications
FDA
Export Markets
ASEAN, Europe, Japan & South Korea, Central Asia, Africa, the Middle East, Latin America
Website
www.maccura.com
Company Introduction
Maccura Biotechnology Co., Ltd. (referred to as “Maccura”) is a Chinese high-tech enterprise focusing on the in vitro diagnostics (IVD) sector. Founded in 1994, the company is headquartered in Chengdu, Sichuan Province.
Over more than three decades of development, Maccura has built a full industrial chain covering biological raw materials, medical laboratory products and professional supporting services. It boasts systematic expertise in the R&D and manufacturing of IVD instruments, reagents, calibrators and quality control materials. Its product portfolio spans multiple technical platforms including clinical chemistry, immunology, coagulation, urinalysis and molecular diagnostics, capable of meeting over 90% of testing demands in medical laboratories.
Maccura attaches great importance to R&D and innovation, investing 25% to 30% of its annual profits in research and development. Endowed with robust technical strength, it is the first Chinese enterprise to be listed in the Joint Committee for Traceability in Laboratory Medicine (JCTLM) database of medical reference measurement laboratories, and a cooperative member of the Institute for Reference Materials and Measurements (IRMM) under the European Commission, participating in value assignment for international reference materials. As of 2025, the company has obtained a total of 644 domestic patents and 516 product registration certificates.
At present, Maccura’s products reach more than 100 countries and regions worldwide via over 300 overseas distributors. The company was listed on the ChiNext board of the Shenzhen Stock Exchange in 2015. In recent years, it has entered a new development phase focused on building intelligent laboratories through automated and smart products, and actively explores the application of artificial intelligence in auxiliary testing and related fields.
Main Products
Fully Automated Hematology Analyzer F880; Fully Automated Hematology Analyzer F600; Fully Automated Chemiluminescence Analyzer i800; Fully Automated Chemiluminescence Analyzer i6000; Fully Automated Coagulation Analyzer H3800; Laboratory-Wide Intelligent Pipeline Tla Labas mix
